Transform RWE & AI into Decision-Grade Evidence & Drive Commercial Impact

Access Robust Datasets, Successfully Harness AI, & Streamline Integrated Evidence Planning to Identify Commercial Opportunities, Drive Efficiency, Support Regulatory & HTA Decision-Making, & Accelerate Speed to Market

Real-world evidence has reached an inflection point. As AI, advanced analytics and the evolving European Health Data Space reshape evidence generation, RWE is becoming a strategic driver of drug development, regulatory strategy and market access. The challenge now is turning increasingly complex datasets into robust, actionable evidence.

The 4th IMPACCT Real World Evidence Summit Europe brings together senior RWE, Evidence Generation, Medical Affairs and Market Access leaders to explore how to build regulatory-grade datasets, govern AI responsibly, navigate fragmented European data landscapes and embed RWE earlier through integrated evidence planning. Hear practical case studies from Pfizer, AstraZeneca, Novartis, Bayer, Novo Nordisk, UCB, Gilead, Boehringer Ingelheim, Takeda and more.

Beyond the presentations, interactive roundtables, debates, problem-solving clinics and dedicated networking create opportunities to exchange honest insights, tackle shared challenges and build lasting relationships with peers.

I especially enjoyed the strong collaboration with colleagues, the high-quality discussions during our sessions, and the positive engagement from participants

Head Global RWE, Boehringer Ingelheim

Boehringer Ingelheim - 4th IMPACCT Real World Evidence Summit Europe

Really great content, great speaker line up and super valuable to have multiple company representatives there to share their experiences

Eli Lilly & Co

Eli Lilly & Co - 4th IMPACCT Real World Evidence Summit Europe

High level of open sharing and trustful conversations despite the competitive elements of being the industry. We were really peers discussing real-life challenges and experiences

Director & Head of RWE & Epidemiology, Lundbeck

Lundbeck - 4th IMPACCT Real World Evidence Summit Europe

Explore the Full Event Guide

  • Explore real-world case studies from Pfizer, AstraZeneca, Bayer, UCB and more
  • Discover practical AI applications across the RWE lifecycle
  • Unpack Europe's evolving health data landscape and EHDS
  • Explore new interactive sessions, including RWE Confessions and our Problem-Solving Clinic
  • Find dedicated networking opportunities to connect with senior RWE, Evidence Generation and Market Access leaders

2027 Speakers

What To Expect

19+

Biopharma Experts Sharing Practical RWE Case Studies

8+

Hours of Dedicated Networking With RWE & Evidence Generation Leaders

3

Days Exploring AI, EHDS & Regulatory-Grade Evidence

2

Hands-On Workshops Tackling Emerging RWE Challenges

12+

Informative Case Studies Across the RWE Lifecycle

2027 Partners

Attending Companies Include

Speaker addressing crowd
Explore the 2027 Agenda

Discover practical insights from leading RWE, Evidence Generation and Market Access experts through real-world case studies, interactive discussions and hands-on workshops.

Crowd Networking
Partner With Us

Showcase how your solutions help pharma and biotech teams unlock real-world data and advance evidence generation, from data providers and AI analytics platforms to RWE consultancy.

Panel Discussion
Connect Across the RWE Lifecycle

Network with senior leaders across RWE, Medical Affairs and Market Access to exchange practical insights, tackle shared challenges and build collaborations that maximise the value of real-world evidence.